Medeon Biodesign, Inc. is an advanced medical technology development company co-founded in 2012 by the YFY Group along with serial entrepreneur Dr. Yue-Teh Jang and Taiwan Global Biofund. The company was listed on the Taipei Exchange in 2016.
Medeon Biodesign specializes in the development, design and international licensing of medical device products with high barriers and market value, with a focus on devices for minimally invasive surgery that provide immediate relief for patient symptoms and are easy to operate. The company’s success is built on Dr. Jang’s extensive device development and international licensing experiences in the field, combined with superior design and manufacturing resources both domestically and abroad, as well as its own clinical application and verification capabilities.
Medeon Biodesign currently has three series of products—for use in laparoscopic surgery, cardiac catheterization, and heart valve replacement surgery—that have either received regulatory approval or are undergoing clinical trials. The company is also continuing to develop urological and other minimally invasive surgical instruments.Medeon Biodesign